Gryrotonic Training in Behcet-diseased Elders With Breast Cancer
gryrotonic training may be a good exercise modality in Behcet-diseased elders with breast cancer
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
forty Behcet-diseased elders with breast cancer will randomy divide into group I (receive gyrotonic exercise three session weekly for 12 week) or group II (wait list)
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Ali MA Ismail, PhD
- Número de teléfono: +201005154209
- Correo electrónico: ali.mohamed@pt.cu.edu.eg
Copia de seguridad de contactos de estudio
- Nombre: fatma mohamed, PhD
- Número de teléfono: 01031321109
- Correo electrónico: fatma1995@gmail.com
Ubicaciones de estudio
-
-
Dokki
-
Giza, Dokki, Egipto
- Reclutamiento
- Cairo University
-
Contacto:
- ali ismail, lecturer
- Número de teléfono: 02 01005154209
- Correo electrónico: ali.mohamed@pt.cu.edu.eg
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- beast cancer survivors
- behcet diseas patients
Exclusion Criteria:
- cardiac or repiratory or renal failure patients
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: group number 1
twenty Behcet-diseased elders who survived from breast cancer will receive gyrotonic exercise three session weekly for 12 week. the session will 45 min |
twnety Behcet-diseased elders who survived from breast cancer will receive gyrotonic exercise three session weekly for 12 week. the session will last for 45 min |
|
Sin intervención: group number 2
twenty Behcet-diseased elders who survivied from breast cancer will be wait list for 12 weeks |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Short Physical Performance Battery
Periodo de tiempo: it will be measured after 12 weeks
|
the total score will be calcualted |
it will be measured after 12 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Dual task gait speed
Periodo de tiempo: It will be measured after 12 weeks
|
this task assess gait speed |
It will be measured after 12 weeks
|
|
Four-square step test
Periodo de tiempo: It will be measured after 12 weeks
|
it is fucntional balnce test |
It will be measured after 12 weeks
|
|
grip strenghts
Periodo de tiempo: It will be measured after 12 weeks
|
it is a measure of grip strenghths in dominant hand |
It will be measured after 12 weeks
|
|
time up- and go testing
Periodo de tiempo: It will be measured after 12 weeks
|
it is a measure of fall risk |
It will be measured after 12 weeks
|
|
sit-to-stand 30-second testing
Periodo de tiempo: It will be measured after 12 weeks
|
asess number of repteations of sit-to-staning in 30 seconds |
It will be measured after 12 weeks
|
|
six minute walking testingg
Periodo de tiempo: It will be measured after 12 weeks
|
distance covered by subject in six minutes wil be assessed |
It will be measured after 12 weeks
|
|
10-meters walking testing
Periodo de tiempo: It will be measured after 12 weeks
|
time covered for walking for ten meter will be assessed |
It will be measured after 12 weeks
|
|
trunk-flexor McGill core endurance test
Periodo de tiempo: It will be measured after 12 weeks
|
this test will assess endurance of trunk flexors |
It will be measured after 12 weeks
|
|
trunk-extensor McGill core endurance test
Periodo de tiempo: It will be measured after 12 weeks
|
this test will assess endurance of trunk extensors |
It will be measured after 12 weeks
|
|
right-lateral-trunk-bending McGill core endurance test
Periodo de tiempo: It will be measured after 12 weeks
|
this test will assess endurance of right lateral trunk bendors |
It will be measured after 12 weeks
|
|
left-lateral-trunk-bending McGill core endurance test
Periodo de tiempo: It will be measured after 12 weeks
|
this test will assess endurance of left lateral trunk bendors |
It will be measured after 12 weeks
|
|
arm flexion in thrity seconds
Periodo de tiempo: It will be measured after 12 weeks
|
it will assess numbers (repeations) of arm flexion in thirty second |
It will be measured after 12 weeks
|
|
maximal nubmer of push up
Periodo de tiempo: It will be measured after 12 weeks
|
this will assess maximal number of performed psh ups in speciifc time |
It will be measured after 12 weeks
|
|
behcet disease quality of life
Periodo de tiempo: It will be measured after 12 weeks
|
questioanire that will assess life quality in behcet disease (total score will be estiamted) |
It will be measured after 12 weeks
|
|
total score of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it is a questioaire asess quality of life |
It will be measured after 12 weeks
|
|
physical fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it is a questioaire asess physical fucntion related quality of life |
It will be measured after 12 weeks
|
|
role fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it is a questioaire asess role fucntion related quality of life |
It will be measured after 12 weeks
|
|
emotional fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it is a questioaire asess emotional fucntion related quality of life |
It will be measured after 12 weeks
|
|
cognitive fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it is a questioaire asess cognitive fucntion related quality of life |
It will be measured after 12 weeks
|
|
social fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it is a questioaire asess social fucntion related quality of life |
It will be measured after 12 weeks
|
|
fatigue fucntioning subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it is a questioaire asess fatigue |
It will be measured after 12 weeks
|
|
nausea-vomiting subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it is a questioaire asess nausea-vomiting |
It will be measured after 12 weeks
|
|
pain subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it will assess pain |
It will be measured after 12 weeks
|
|
dyspnea subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it will assess dyspnea |
It will be measured after 12 weeks
|
|
insomnia subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it will assess insomnia |
It will be measured after 12 weeks
|
|
appetite-loss subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it will assess appetite loss |
It will be measured after 12 weeks
|
|
constipation subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it will assess constipation |
It will be measured after 12 weeks
|
|
diarrhea subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it will assess diarrhea |
It will be measured after 12 weeks
|
|
financial difficulties subscale of European-Organization-for-Research and Treatment-of-Cancer Quality-of-Life Questionnaire-Core 30
Periodo de tiempo: It will be measured after 12 weeks
|
it will assess financial difficulties |
It will be measured after 12 weeks
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Ali MA Ismail, phd, Cairo University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
- Enfermedades de la Boca
- Enfermedades Estomatognáticas
- Enfermedades Vasculares
- Enfermedades cardiovasculares
- Neoplasias por sitio
- Neoplasias
- Enfermedades Genéticas Congénitas
- Enfermedades de los ojos
- Enfermedades de la piel
- Enfermedades de los senos
- Enfermedades De La Piel Vasculares
- Enfermedades De La Piel Genéticas
- Enfermedades uveales
- Vasculitis
- Panuveítis
- Uveítis Anterior
- Uveítis
- Enfermedades autoinflamatorias hereditarias
- Enfermedades y anomalías congénitas, hereditarias y neonatales
- Enfermedades de la piel y del tejido conectivo
- Neoplasias de mama
- Síndrome de Behçet
- Actividad motora
- Movimiento
- Fenómenos fisiológicos musculoesqueléticos
- Fenómenos fisiológicos musculoesqueléticos y neuronales
- Ejercicio
Otros números de identificación del estudio
- IRB00014233-118
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .